Biotech grants

Between cycles

Funds non-drug research that removes a barrier to diagnosing, monitoring or accurately predicting the course of Alzheimer's disease and related dementias.

Between cycles

Funds research into Alzheimer's risk factors or prevention strategies, aimed at stopping the disease before it starts rather than treating it after.

Between cycles

Funds developing or validating the biomarkers and outcome measures that make ALS clinical trials sharper, not the trials themselves.

Between cycles

Funds a phase 1 or small phase 2 ALS clinical trial that must start within a year of the award, with a biomarker built in for any drug, biologic or device.

Between cycles

Funds preclinical-to-IND-enabling work on an ALS drug that already has proof-of-concept efficacy data and a lead compound in hand.

Between cycles

Funds an early, hypothesis-driven ALS drug or therapy idea before there's data proving it will work.

Between cycles

Funds a human study of arthritis at whichever of two scales the evidence supports — a pilot or a full trial.

Between cycles

Funds preclinical or animal arthritis research that's too applied to count as basic science and not yet ready for people.

Between cycles

Funds a clinical trial of a new autism treatment, product or device, from a small proof-of-concept study up to a full efficacy trial.

Between cycles

Funds breast cancer research mature enough to run a small clinical trial, though a trial is not required at this level.

Between cycles

Funds a single, large breast cancer research effort built around a clinical trial that has to happen.

Between cycles

Funds a large, multi-institution team of scientists, clinicians and advocates tackling one breast cancer problem too big for a single lab.

Between cycles

Funds preclinical or clinical Duchenne muscular dystrophy research, at a smaller or a larger funding level.

Between cycles

Funds an early-stage idea in Duchenne muscular dystrophy research, without requiring a clinical trial.

Between cycles

Funds drug discovery and therapy development for hearing loss from military-relevant injury, not tinnitus or balance disorders.

Between cycles

Funds an early-career researcher's kidney cancer project alongside paired mentoring inside the program's own investigator academy.

Between cycles

Funds an early-stage kidney cancer research idea built on a clear hypothesis and a strong scientific rationale.

Between cycles

Funds an early-stage, high-risk lung cancer research idea, with a separate track for investigators new to independent research.

Between cycles

Funds translational lung cancer research moving toward the clinic, at either a late preclinical stage or a pilot clinical trial.

Between cycles

Funds a multi-investigator research program tackling one shared question in rare melanoma, split across two or three linked projects.

Between cycles

Funds an exploratory, high-risk melanoma research idea, where existing preliminary data is discouraged rather than expected.

Between cycles

Funds an early-career melanoma researcher's project alongside guided mentoring inside the program's own academy.

Between cycles

Funds a multi-investigator melanoma research team through a pre-application screen, with each partner named on their own award.

Between cycles

Funds early, untested ideas in combat-relevant burn care meant to generate the preliminary data a later study would need.